INTEGRATED LANGUAGE SOLUTIONS

Translation of COAs & eCOAs

Clinical Outcome Assessments (COAs) are one of the most sensitive pieces of the clinical trial puzzle, as they condition the successful collection of data required to validate endpoints. Working with IQVIA Language Solutions on linguistic validation and management of COAs means you get all the benefits of integrated language solutions: speed, quality and cost efficiency

New Publication: Advancing COA Linguistic Validation with Responsible AI
Analysis and Good Practice Recommendations

INTEGRATED LANGUAGE SOLUTIONS

Fast, reliable, efficient

The translation of COA instruments for global studies is a complex, timely and costly process.

IQVIA challenges the status quo with its integrated language solutions model. The result is faster turnaround of highly sensitive COA translations while elevating quality and reliability.

As regulatory and time-to-market pressure increase, choosing the right language partner to enable your global trials is critical. IQVIA is the partner of choice for expertise, innovation and scalability in eCOA translation.

What is linguistic validation, and why is it critical?
Linguistic validation is a critical step in the development and execution of clinical trials, particularly those that involve multinational and multicultural patient populations. The term “linguistic validation” refers to the process of adapting Clinical Outcome Assessments (COAs), often questionnaires or surveys, from their original language to the language of the target population. The process involves ensuring that the translated version of the instrument accurately captures the intended meaning, is culturally appropriate, and is understandable to the target population.

INTEGRATED LANGUAGE SOLUTIONS

COA translation expertise

Because IQVIA have been managing global clinical trials for decades, we have developed unique expertise in handling Clinical Outcome Assessment (COA) translations.

From innovative multilingual migration tools to well-honed linguistic validation processes, we support our clients in making their Patient Reported Outcomes (PROs), Clinical Reported Outcomes (ClinROs), Observer Reported Outcomes (ObsPROs) and other COA materials appropriate for every target population.

LANGUAGE SOLUTIONS FOR COAs

Why choose IQVIA for eCOA translation?

Speed

Because of our integration into IQVIA’s end-to-end COA and eCOA management processes, our eCOA migration and linguistic validation processes operate significantly faster than average. Our existing library of translated COAs also allows for faster roll-out where applicable.

Cost efficiency

The efficiencies achieved by integrating our solutions directly into wider processes have immediate and longer-term benefits for our customers, allowing them to achieve more with less.

Therapeutic expertise

The IQVIA Language Solutions team is deeply rooted within the wider IQVIA structure and benefits from an unmatched wealth of clinical knowledge. From migration right through to certification, our entire process is built to guarantee quality and compliance in any language.

COA & eCOA expertise

We have decades of experience handling all aspects of COA implementation: instrument research and maintenance, COA copyright and licensing, linguistic validation and cognitive interviews, eCOA migration and more. We support all COA variants, including PROs, ClinROs, ObsROs, and PerfROs.

INTEGRATED LANGUAGE SOLUTIONS

IQVIA’s eCOA library

Because we have been managing clinical trials on the global stage for decades, we know how critical quick setup and deployment of eCOAs can be.

IQVIA’s eCOA library contains over 1,700 pre-configured, copyrighted assessments. In combination with our language processes, this allows sponsors to deploy studies faster, anywhere.

IQVIA Language Solutions

Trusted language solutions for the speed of science

 

IQVIA Language Solutions helps organizations overcome language, cultural and regulatory barriers with AI-powered translation, scientific expertise and integrated workflows designed specifically for life sciences.